The immunohistochemistry we performed indicated that PTGFRN expression was undetectable in various non‐cancerous tissues, whereas PTGFRN expression was significantly elevated in several cancers, including mesothelioma and medulloblastoma. The gene discussed is PTGFRN; the disease is medulloblastoma.